SCHEMBL29112210

SCHEMBL29112210

CC(C)(C)c1nnccc1OC(N)=O

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
DYRK1A Q13627 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29100724 0.77 MAPK1 (0.39) MEN1KMT2A
SCHEMBL25791636 0.74 CA12 (0.34)
SCHEMBL29131956 0.72 SMN1; SMN2 (0.32)
SCHEMBL29079785 0.71 NNMT (0.44) KMT2ADYRK1A
SCHEMBL29099664 0.68 CYP3A4 (0.38) MEN1KMT2A
SCHEMBL28969394 0.68 PTGDR2 (0.33) MEN1KMT2ADYRK1A
SCHEMBL1164137 0.66 KCNJ1 (0.42) KMT2A
SCHEMBL28519120 0.66 DYRK1A (0.33) MEN1KMT2ADYRK1A
SCHEMBL27947755 0.66 PTGDR2 (0.40) MEN1KMT2A
SCHEMBL11466585 0.65 TDP1 (0.58) MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117120442-A Tricyclic compounds useful for treating cancer, autoimmune disorders, and inflammatory disorders 薛定谔公司 2023-11-24 CN disclosed